newsfilter
← Latest News
GlobeNewswire·

Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors

BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (NASDAQ:AVLN) ("Avalyn" or the "Company"), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the